What role can EIS and venture capital play within an investment portfolio? In this opening presentation from September's Tax Advantaged Forum, Brian Moretta of Hardman & Co explains the potential portfolio diversification benefits of investing in venture capital and EIS. Brian outlines the different stages at which venture-backed companies operate, from developing an initial product and finding product-market fit through to scaling, and explains how these investments differ from quoted equities. He also provides an overview of the main EIS tax advantages, including income tax relief, capital gains tax relief and deferral, loss relief and potential inheritance tax benefits. Brian also discusses recent changes to the EIS rules and how these may affect investment decisions. A useful introduction to EIS for investors and advisers considering the role of venture capital within a broader portfolio. Watch the full event on-demand: https://us06web.zoom.us/webinar/register/1017829083259/WN_3lPsCebMRvCmdzG3JUKxAA Read more on our website and check out our fund reviews here: https://hardmanandco.com/research/tax-advantaged-research/ Key topics covered: EIS investing Venture capital and portfolio diversification Early-stage and growth investing Product-market fit and scaling EIS income tax relief Capital gains tax relief and deferral EIS loss relief Business Relief and inheritance tax Recent changes to EIS rules EIS vs VCTs September 2026 Tax Advantaged Forum: Dr Brian Moretta, Head of Tax Advantaged Research at Hardman & Co, was speaking at Hardman & Co's Tax Advantaged Forum, hosted in association with GrowthInvest. We also heard from EverQuest Capital Partners, MMC Ventures, Parkwalk and PXN Investments. Important notice: This content has been prepared purely for information purposes, and should not be construed as an offer, or the solicitation of an offer, to buy or sell any security, product, service or investment. Nor should it be viewed as a substitute for viewers’ own due diligence. The companies or legal entities covered in this content may or may not pay us a fixed fee for this content to be made available. This content contains factually correct information at the time of publication which has been provided to us by our client to which the content relates, who have also confirmed that it has not been misleadingly presented. Investing in early-stage growth companies is speculative and involves a high degree of risk. An investor could lose all or a substantial amount of his or her investment, and the securities, legal entities or alternative investments mentioned in this content may not be suitable or appropriate for all investors. Access to liquidity may be totally or highly restricted. Each investor’s particular needs, investment objectives and financial situation were not taken into account in the preparation of this content. Each investor must make his or her own independent decisions and obtain their own independent advice regarding any information, projects, securities, tax treatment or financial instruments mentioned herein. The fact that Hardman & Co has made available through this content various information constitutes neither a recommendation to enter into a particular transaction nor a representation that any financial instrument is suitable or appropriate for you. Each investor should consider whether an investment strategy of the purchase or sale of any product or security is appropriate for them in the light of their investment needs, objectives and financial circumstances. For more information, please read our full disclaimers: www.hardmanandco.com/research-disclosures www.hardmanandco.com/disclaimer #EIS #EISInvesting #VentureCapital #TaxAdvantagedInvesting #TaxRelief #PortfolioDiversification #GrowthInvesting #UKInvesting
